Iodine Software
AI software that scans hospital charts to catch missed billing and documentation gaps.
Iodine's hospital data and integrations still count for something, but Epic's native tools and ambient AI scribes are both closing in from opposite ends of the workflow.
Iodine Software checks hospital medical records to find mistakes that cost money and compliance problems. It built its strength over 15 years by collecting data from about one-third of all US hospital patients and by being wired deep into the computers that hospitals already use. The main threat comes from newer AI tools like Abridge and Nuance DAX that catch documentation errors right when doctors are typing, rather than afterward, plus huge companies like Epic are now building similar tools themselves. The turning point will be whether Iodine, now part of Waystar after an October 2025 takeover, can keep hospitals buying its service after the company cuts its workforce from 240-260 people down to 51-200, or whether hospitals switch to cheaper or faster competitors.
Abridge or Nuance DAX announces a named hospital system win for mid-cycle reimbursement or integrity checks. Shows ambient point-of-care tools are displacing Iodine's post-documentation review model.
Epic publishes or demos a native CDI product with named hospital adoption. Shows the EHR incumbent is closing the integration gap that protected Iodine.
- $1.25B Waystar acquisition price
- ~10% YoY growth guided for 2026
- Data covers ~1/3 of US inpatient discharges
- Iodine 2026 revenue growth decelerating to ~10% YoY flagged by analysts Feb 2026.
- Headcount contraction from ~250 to 51-200 band amid $14M cost-synergy integration.
- Ambient point-of-care AI tools (Abridge, Nuance DAX) encroaching on mid-cycle value proposition.
- Standalone Iodine brand being dissolved into Waystar, diluting market identity.
- Advent International 18-month share lockup expiry around April 2027 could pressure Waystar stock.
| Rival | Direction | Evidence |
|---|---|---|
| Epic | gaining on | EHR vendor moving into CDI space, flagged by Waystar management Feb 2026 |
| 3M/Solventum | contesting | Large incumbent CDI/AI coding competitor per KLAS Research coverage |
| Abridge | gaining on | Ambient documentation tool bundling integrity checks upstream, noted mid-2026 |
| Nuance (Microsoft) | contesting | Speech-recognition CDI/ambient tool DAX competing at point-of-care, 2026 |
| Optum (UnitedHealth Group) | contesting | Optum CDI ranked market-average competitor per KLAS, ongoing as of 2026 |
- Is Iodine Software still an independent company?
- No. Waystar Holding Corp closed its acquisition of Iodine Software on October 1, 2025, for a total enterprise value of $1.25 billion, and Iodine now operates as a wholly owned Waystar subsidiary with its standalone brand being retired.
- Is Iodine Software profitable?
- Iodine no longer reports standalone financials. Its parent Waystar posted a 42% EBITDA margin as of Q4 2025 (reported February 17, 2026), with Iodine contributing $31 million in Q4 2025 revenue toward that combined result.
- Are there layoffs happening at Iodine Software?
- Third-party trackers show contraction: Iodine had roughly 240 to 257 employees through early 2026, but LeadIQ listed the post-acquisition entity in a 51 to 200 employee band as of March 16, 2026, consistent with Waystar's targeted $14 million cost-synergy plan.
- Could AI replace Iodine Software's core product?
- Iodine's own AI already automates chart review and query generation once done manually by CDI specialists. The bigger risk is ambient point-of-care tools like Abridge and Nuance DAX bundling integrity checks upstream, per industry coverage from mid-2026.
- Who is Iodine Software's biggest competitor?
- Direct CDI rivals include 3M/Solventum 360 Encompass, Optum CDI, and Microsoft-owned Nuance, per KLAS Research rankings. Newer AI-native threats are Abridge, Nuance DAX, Ambience, Suki AI, and DeepScribe, which are moving CDI checks to point-of-care as of 2026.
- Who owns Iodine Software now?
- Waystar Holding Corp (Nasdaq: WAY) owns Iodine Software after closing a $1.25 billion acquisition on October 1, 2025. Advent International, previously Iodine's largest shareholder, received Waystar stock with an 18-month lockup expiring around April 2027.
- 2026-04-29Waystar launches AI-powered recoupment solutions using combined Iodine and Waystar datasets
- 2026-03-16LeadIQ lists post-acquisition Iodine entity in 51-200 employee headcount band
- 2026-02-17Waystar Q4 2025 earnings show Iodine $31M quarterly revenue, 2026 guide of $125-130M
- 2025-10-01Waystar closes $1.25 billion acquisition of Iodine Software
- 2025-07-23Waystar announces definitive agreement to acquire Iodine Software
- 2025-05-15Iodine launches next-generation AwarePreBill revenue-leakage solution
- 2024-02-05Iodine launches AwareUM utilization-management product
- 2021-12Advent International makes growth investment valuing Iodine above $1 billion
- 2020-07-27Iodine unveils AwareCDI software suite for mid-revenue-cycle leakage
- 2010Iodine Software founded in Austin, Texas
- Waystar to Acquire Iodine Software (2025-07-23)
- Waystar Closes Acquisition of Iodine Software (2025-10-01)
- RCM company Waystar buys Iodine Software for $1.25B (2025-10-03)
- Iodine Software Launches Next-Generation Pre-Bill Solution (2025-05-15)
- Iodine Software Unveils AwareCDI (2020-07-27)
- Waystar Holding Corp (WAY) Q4 2025 Earnings Call Highlights (2026-02-17)
- Waystar's AI Push Drives Record Growth and 42% EBITDA Margin (2026-02-17)
- Where is Iodine Software Located? (2024-02-05)
- Iodine Software, now part of Waystar Employee Directory (2026-03-16)
- The Best CDI Companies of 2026 (2026-06-30)
- Iodine Software Introduces AwareUM (2024-02-05)
- Waystar Reports First Quarter 2026 Results (2026-04-29)